Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: drugs Clear Filter

Doctors Are Warning That Ozempic’s Severe Side Effects May Outweigh Its Benefits

Image by Roberto Pfeil / picture alliance via Getty / Futurism Rx/Medicines As weight loss jabs like Ozempic and Wegovy become ever more popular, doctors are growing increasingly concerned about their gnarly side effects. As Germany's Deutsche Welle notes, people who take glucagon-like peptide-1 (GLP-1) agonist/receptors, the class of drugs that the popular shots fall under, have reported everything from stomach issues and vision changes to erectile dysfunction and even suicide. Though clinic

First malaria treatment for babies approved for use

First malaria treatment for babies approved for use 4 days ago Share Save Dominic Hughes Global Health Correspondent Share Save Getty Images Malaria drugs for children do exist, but there are no treatments specifically for babies The first malaria treatment suitable for babies and very young children has been approved for use. It's expected to be rolled out in African countries within weeks. Until now there have been no approved malaria drugs specifically for babies. Instead they have been tr

New Study Flips Everything We Know About Addiction Upside Down

Since the 1970s, countless experts and the US government have sold the public a simple explanation for drug addiction, now clinically called substance abuse disorder: the myth of the gateway drug. The gateway drug — usually cast as weed, alcohol, tobacco, or inhalants — refers to the theory that the earlier a kid starts using drugs, the more likely they are to get into the harder stuff later in life, like heroin or cocaine. Though the idea was pioneered as early as the 1930s, the policy term wa

These Genetically Modified Mice Make Their Own ‘Ozempic’

The popularity of Ozempic and Wegovy as diabetes and weight loss medications has skyrocketed. But how far would people go to avoid one of their major drawbacks—the need for weekly injections? A study out today shows it’s possible to genetically modify mice to make their own Ozempic-like drugs. Scientists in Japan led the research, which involved gene-editing mice’s livers to produce an internal supply of exenatide, a first-generation GLP-1 drug. The edited mice were able to sustain levels of th

The Download: how to clean up AI data centers, and weight-loss drugs’ side effects

In a sandy industrial lot outside Reno, Nevada, rows of battery packs that once propelled electric vehicles are now powering a small AI data center. Redwood Materials, one of the US’s largest battery recycling companies, showed off this array of energy storage modules, sitting on cinder blocks and wrapped in waterproof plastic, during a press tour at its headquarters on June 26. The event marked the launch of the company's new business line, Redwood Energy, which will initially repurpose (

Spike in Pancreas Problems From Weight-Loss Drugs Prompts Investigation

Ozempic and similar GLP-1 drugs seem to be hurting some people’s pancreas. UK health officials are planning to study the link between GLP-1 use and acute pancreatitis, following an increase in reported cases this year. The Guardian reported Tuesday that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is launching an investigation into pancreatitis associated with the drug class. Hundreds of residents have complained about pancreas problems after taking semaglutide or other r

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution of the partnership Monday, just two months after it was struck. Novo claims that Hims is using “deceptive marketing” to widely sell compounded semaglutide t

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s

Eli Lilly’s daily anti-obesity pill orforglipron appears to be as good at spurring weight loss and lowering blood sugar in diabetes patients as popular injectable GLP-1 drugs like Ozempic, according to new data from a Phase 3 trial. The results were announced today at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine. Eli Lilly is the maker of the blockbuster GLP-1 drug tirzepatide, approved as Mounjaro for type 2 diabetes and Zepbound

Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study

When it comes to weight loss, surgery still reigns supreme. Research out today shows that people undergoing bariatric surgery tend to lose significantly more weight than people taking the newest, most effective GLP-1 medications for obesity. Scientists at New York University conducted the study, which analyzed real-world data from obesity patients. People who received surgery lost five times more weight over a two year span on average than those who were prescribed a GLP-1 drug, they found. The

Threat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs

The Food and Drug Administration’s 2022 inspection of the Sun Pharma factory in India warned of contaminations and deficiencies. But the plant received permission from the FDA to continue shipping more than a dozen generic medications to Americans. We are still reporting. If you are a current or former FDA employee or someone in the industry with information about the agency, the safety of generic drugs, or the manufacturers that make them, our team wants to hear from you. Megan Rose can be rea

Doctors Concerned By Massive Uptick In Teens Taking Ozempic

Image by Roberto Pfeil / picture alliance via Getty / Futurism Rx/Medicines Teens are being prescribed Ozempic and similar drugs more than ever before — and some doctors are worried about what the trend could mean. In interviews with Reuters and Raleigh, North Carolina's WRAL, doctors expressed disquiet at recent studies that found that are kids being prescribed the uber-popular jabs at increasing rates. Two recent studies, the first from the from the data firm Truveta and the second from Eve

Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage

Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been